Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Bryan Williams, Thomas M. MacDonald, S. V. Morant, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 6, pp. 464-475
Open Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
European Heart Journal (2018) Vol. 39, Iss. 33, pp. 3021-3104
Open Access | Times Cited: 8813
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4328
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger, Claudio Borghi, Fadi J. Charchar, et al.
Hypertension (2020) Vol. 75, Iss. 6, pp. 1334-1357
Open Access | Times Cited: 3172
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
Journal of Hypertension (2018) Vol. 36, Iss. 10, pp. 1953-2041
Open Access | Times Cited: 2578
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 116, Iss. 3, pp. 516-658
Open Access | Times Cited: 787
2020 International Society of Hypertension global hypertension practice guidelines
Thomas Unger, Claudio Borghi, Fadi J. Charchar, et al.
Journal of Hypertension (2020) Vol. 38, Iss. 6, pp. 982-1004
Open Access | Times Cited: 652
Obesity, kidney dysfunction and hypertension: mechanistic links
John E. Hall, Jussara M. do Carmo, Alexandre A. da Silva, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 367-385
Open Access | Times Cited: 494
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
Doreen M. Rabi, Kerry A. McBrien, Ruth Sapir‐Pichhadze, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 5, pp. 596-624
Closed Access | Times Cited: 480
The Unrecognized Prevalence of Primary Aldosteronism
Jenifer M. Brown, Mohammed Siddiqui, David A. Calhoun, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 1, pp. 10-20
Open Access | Times Cited: 427
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 382
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
The Lancet (2019) Vol. 394, Iss. 10208, pp. 1540-1550
Open Access | Times Cited: 296
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
Alexandre A. da Silva, Jussara M. do Carmo, Xuan Li, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 5, pp. 671-682
Open Access | Times Cited: 263
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
Anand Vaidya, Paolo Mulatero, René Baudrand, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 6, pp. 1057-1088
Open Access | Times Cited: 226
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
Mason W. Freeman, Yuan‐Di C. Halvorsen, William Marshall, et al.
New England Journal of Medicine (2022) Vol. 388, Iss. 5, pp. 395-405
Open Access | Times Cited: 215
Prevalence of Apparent Treatment-Resistant Hypertension in the United States
Robert M. Carey, Swati Sakhuja, David A. Calhoun, et al.
Hypertension (2019) Vol. 73, Iss. 2, pp. 424-431
Open Access | Times Cited: 172
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 90
Primary aldosteronism — a multidimensional syndrome
Adina F. Turcu, Jun Yang, Anand Vaidya
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 11, pp. 665-682
Closed Access | Times Cited: 82
2024 Clinical practice guidelines for Hypertension in adults
Ж. Д. Кобалава, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 9, pp. 6117-6117
Open Access | Times Cited: 19
Screening Rates for Primary Aldosteronism in Resistant Hypertension
Gilad Jaffe, Zachary Gray, Gomathi Krishnan, et al.
Hypertension (2020) Vol. 75, Iss. 3, pp. 650-659
Open Access | Times Cited: 125
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans
Jordana B. Cohen, Debbie L. Cohen, Daniel S. Herman, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 3, pp. 289-297
Open Access | Times Cited: 119
Hypertension in Blacks
J. David Spence, Brian Rayner
Hypertension (2018) Vol. 72, Iss. 2, pp. 263-269
Open Access | Times Cited: 114
Treatment of Resistant and Refractory Hypertension
Maria Czarina Acelajado, Zachary H. Hughes, Suzanne Oparil, et al.
Circulation Research (2019) Vol. 124, Iss. 7, pp. 1061-1070
Open Access | Times Cited: 109
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
Anand Vaidya, Robert M. Carey
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3771-3783
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top